| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 05/21/1997 | CN1150155A Antiadhesive piperidine-and pyrrolidinecarboxylic acids |
| 05/21/1997 | CN1150023A Chinese medicine for treatment of woman postpartum disease |
| 05/21/1997 | CN1034939C Process for preparing indolone and indoldione derivatives with cholinergic activity |
| 05/21/1997 | CN1034930C Ornithine decarboxylase inhibiting branched aminooxy amino alkane derivatives and use thereof |
| 05/21/1997 | CN1034929C Ornithine decarboxylase inhibiting cyclic aminooxy compounds and use thereof |
| 05/21/1997 | CA2190693A1 Substituted benzenedicarboxylic acid diguanides, process for their preparation, their use as a medicament or diagnostic, and medicament containing them |
| 05/21/1997 | CA2190692A1 Substituted benzenedicarboxylic acid diguanides, process for their preparation, their use as a medicament or diagnostic, and medicament containing them |
| 05/20/1997 | US5631402 Process for preparing aminobenzoic acid derivatives |
| 05/20/1997 | US5631376 Retroviral protease inhibiting compounds |
| 05/20/1997 | US5631373 Alkyl, azido, alkoxy, and fluoro-substituted and fused quinoxalinediones |
| 05/20/1997 | US5631369 Process for preparing benzoic acid derivative intermediates and benzothiophene pharmaceutical agents |
| 05/20/1997 | US5631293 Cardiovascular disorders |
| 05/20/1997 | US5631289 Treatment of calcium deficiency and reducing irritation in intestines |
| 05/20/1997 | US5631287 Storage-stable prostaglandin compositions |
| 05/20/1997 | US5631280 Inhibitors of farnesyl-protein transferase |
| 05/20/1997 | US5631279 Antagonists of neurokinin a |
| 05/20/1997 | US5631267 Method for the treatment of eosinophil-associated diseases by administration of topical anesthetics |
| 05/20/1997 | US5631265 Chemical intermediates with central nervous system activity |
| 05/20/1997 | US5631260 Xanthine epoxides as A1 adenosine receptor agonists and antagonists |
| 05/20/1997 | US5631257 Benzoxazole derivatives |
| 05/20/1997 | US5631256 Antimicrobial quinolone thioureas |
| 05/20/1997 | US5631247 Antilipemic agents, cardiovascular disorders, urogenital disorders and osteoporosis |
| 05/20/1997 | US5631219 Method of stimulating hematopoiesis with hemoglobin |
| 05/20/1997 | US5631022 Picosulfate dosage form |
| 05/20/1997 | US5631011 Hyaluronic acid or derivative; wound healing agents |
| 05/20/1997 | US5630996 Two-step pretargeting methods using improved biotin-active agent conjugates |
| 05/20/1997 | CA2073340C Centrally acting 6,7,8,9-tetrahydro-3h-benz(e)indole heterocyclics |
| 05/20/1997 | CA2044515C Cyclic amide derivatives |
| 05/18/1997 | CA2188485A1 Piperidinylethylamide derivatives as serotonergic agents |
| 05/18/1997 | CA2188484A1 Piperazinyl benzamide derivatives as serotonergic agents |
| 05/15/1997 | WO1997017612A1 Prevention of sudden infant death |
| 05/15/1997 | WO1997017433A1 Tissue-specific and target rna-specific ribozymes |
| 05/15/1997 | WO1997017362A1 Novel amino acid derivatives, methods of producing them, and pharmaceutical compounds containing these compounds |
| 05/15/1997 | WO1997017351A1 Spiro piperidine derivatives as 5mt receptor antagonists |
| 05/15/1997 | WO1997017350A1 Azaspiro derivatives with 5ht1b activity |
| 05/15/1997 | WO1997017345A1 5-phenyl-3-(piperidin-4-yl)-1,3,4-oxadiazol-2(3h)-one derivatives for use as 5-ht4 or h3 receptor ligands |
| 05/15/1997 | WO1997017340A1 Novel imidazole derivatives, method for preparing same, resulting intermediates, pharmaceutical compositions and use of said derivatives as endothelin antagonists |
| 05/15/1997 | WO1997017339A1 Novel imidazole n-benzyldioxol derivatives, method for preparing same, resulting intermediates, pharmaceutical compositions and use of said derivatives as endothelin antagonists |
| 05/15/1997 | WO1997017326A1 Enantiomers of cis-benz[e]indole compounds, their preparation and utility as dopamine-d3 receptor selective agents |
| 05/15/1997 | WO1997017317A1 4-phenyl-4-oxo-butanoic acid derivatives with kynurenine-3-hydroxylase inhibiting activity |
| 05/15/1997 | WO1997017316A1 4-phenyl-4-oxo-2-butenoic acid derivatives with kynurenine-3-hydroxylase inhibiting activity |
| 05/15/1997 | WO1997017087A1 Stabilizing formulation for ngf |
| 05/15/1997 | WO1997017074A1 Treatment of traumatic brain injury |
| 05/15/1997 | WO1997017070A1 Inhibitors of protein isoprenyl transferases |
| 05/15/1997 | WO1997017069A1 Methods for treating resistant tumors |
| 05/15/1997 | WO1997017068A1 Ginkgolides for inhibition of membrane expression |
| 05/15/1997 | WO1997017067A1 Sublingual and buccal administration of selegiline |
| 05/15/1997 | WO1997013781A3 Synthetic peptides that inhibit il-6 activity |
| 05/15/1997 | WO1997011668A3 TUMOR NECROSIS FACTOR ALPHA (TNF-α) INHIBITING PHARMACEUTICALS |
| 05/15/1997 | WO1997001576A3 Phenyl peptides, method for preparing same, and pharmaceutical compositions containing said peptides |
| 05/15/1997 | CA2236543A1 Methods for treating resistant tumors |
| 05/15/1997 | CA2235416A1 Ginkgolides for inhibition of membrane expression |
| 05/15/1997 | CA2234824A1 Treatment of traumatic brain injury |
| 05/15/1997 | CA2190220A1 Sulfonylamino-substituted benzoylguanidines, a process for their preparation, their use as medicament of diagnostic aid, and medicament containing them |
| 05/14/1997 | EP0773226A1 Propiophenone derivative and processes for preparing the same |
| 05/14/1997 | EP0773217A1 Benzothiphene derivatives for treating resistant tumors |
| 05/14/1997 | EP0773026A2 NK-1 receptor antagonists for the treatment of cancer |
| 05/14/1997 | EP0773024A2 Use of N-substituted nicotinamide compounds for the treatment of acute and chronic inflammatory diseases |
| 05/14/1997 | EP0773023A1 New uses for corticotropin releasing factor (CRF) antagonists |
| 05/14/1997 | EP0773022A2 Pharmaceutical composition for the treatment of rhinitus, containing sympathomometic and pantothenol and/or pantothenic acid |
| 05/14/1997 | EP0773019A1 Hyperlipemia remedy |
| 05/14/1997 | EP0772690A1 Recombinant virus vectors |
| 05/14/1997 | EP0772677A1 T cell activation |
| 05/14/1997 | EP0772631A1 Processes for the purification of human recombinant decorin and the detection of guanidinium ions |
| 05/14/1997 | EP0772630A1 Streptogramine derivatives, preparation of same and pharmaceutical compositions containing same |
| 05/14/1997 | EP0772629A1 T cell epitopes of rye grass pollen allergen |
| 05/14/1997 | EP0772619A1 Immunomodulatory oligonucleotides |
| 05/14/1997 | EP0772615A1 IMIDAZO 1,2-a]INDENO 1,2-e]PYRAZINE-2-CARBOXYLIC ACID DERIVATIVES, PREPARATION THEREOF AND DRUGS CONTAINING SAME |
| 05/14/1997 | EP0772613A2 Process for the production of aminoazobicycloalkanes from oximes |
| 05/14/1997 | EP0772610A1 Dihydrobenzofuranes |
| 05/14/1997 | EP0772600A1 1,2-substituted imidazolyl compounds for the treatment of inflammation |
| 05/14/1997 | EP0772596A1 INDOLIZINE sPLA2 INHIBITORS |
| 05/14/1997 | EP0772594A1 Iminoxycarboxylates and derivatives as inhibitors of leukotriene biosynthesis |
| 05/14/1997 | EP0772592A1 1H-INDOLE-1-FUNCTIONAL sPLA 2? INHIBITORS |
| 05/14/1997 | EP0772585A1 Aryloxy and arylthiopropanolamine derivatives useful as beta 3-adrenoreceptor agonists and antagonists of the beta 1 and beta 2-adrenoreceptors and pharmaceutical composition thereof |
| 05/14/1997 | EP0772455A2 Intracellular expression of carboxypeptidase g2 in enzyme prodrug therapy |
| 05/14/1997 | EP0772448A1 CYCLIC ANALOGS OF PTH AND PTHrP |
| 05/14/1997 | EP0772446A1 Anti-adhesion agent |
| 05/14/1997 | EP0772438A1 Methods of reducing scarring in wound healing |
| 05/14/1997 | CN1149876A Perfluoroalkyl ketone inhibitors of elastase and processes for making same |
| 05/14/1997 | CN1149873A Piperazine derivatives as 5HT1A antagonists |
| 05/14/1997 | CN1149870A Substituted pyrazoles having corticotropin-releasing factor (CRF) antagonist activity |
| 05/14/1997 | CN1149833A Acylated enol derivatives as prodrugs of elastase inhibitors |
| 05/14/1997 | CN1149830A Pyridylbisphosphonates for use as therapeutical agent |
| 05/14/1997 | CN1149588A Cyclic bonding inhibitor |
| 05/14/1997 | CN1149583A Enderma agent receptor antagonist |
| 05/14/1997 | CN1149450A Deodoring powder or preparation fortragomaschalia |
| 05/14/1997 | CN1034865C Preparing method for 2-aminopyrimidinone |
| 05/13/1997 | US5629436 Use of N-arylmethylene ethylenediaminetriacetates N-arylmethylene iminodiacetates or N,N'-diarylmethylene ethylenediamineacetates against oxidative stress |
| 05/13/1997 | US5629347 Aromatic compounds, pharmaceutical compositions containing them and their use in therapy |
| 05/13/1997 | US5629338 Tannins and lipase inhibitors containing the same as active ingredients |
| 05/13/1997 | US5629337 Methods for treating asthma using optically pure (-)-zileuton |
| 05/13/1997 | US5629336 Use of glycine/NMDA receptor ligands for the treatment of drug dependence and withdrawal |
| 05/13/1997 | US5629331 2-butyl-3-tetrazolylbiphenylylmethyl-1,3-diazaspirononenone made by reacting corresponding nitrile with alkaline azide and triethylamine hydrochloride in inert polar aprotic solvent, neutralizing salt, crystallizing in one of two ways |
| 05/13/1997 | US5629327 Methods and compositions for inhibition of angiogenesis |
| 05/13/1997 | US5629325 3-pyridyloxymethyl heterocyclic ether compounds useful in controlling chemical synaptic transmission |
| 05/13/1997 | US5629322 Treatment of neurodegenerative disorders, disorders of gastrointestinal motility and inflammation |
| 05/13/1997 | US5629315 Treatment of psoriasis, asthma,osteoporosis, alcoholic hepatitis, and premature labor |
| 05/13/1997 | US5629309 2-substituted indane-2-mercaptoacetylamide disulfide derivatives useful as inhibitors of enkephalinase and ACE |
| 05/13/1997 | US5629293 Single chain peptide compounds having hemoregulatory activity |